AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dignity Health - Chandler Regional Medical Center
Chandler, Arizona, United States
- Adventist Health St. Helena
St. Helena, California, United States
- Vascular Care Connecticut
Darien, Connecticut, United States
- Palm Vascular Centers
Miami Beach, Florida, United States
- Coastal Vascular & Interventional, Pllc
Pensacola, Florida, United States
- Piedmont Heart Institute
Atlanta, Georgia, United States
- Midwest Cardiovascular Research Foundation
Davenport, Iowa, United States
- Cardiovascular Institute of the South
Houma, Louisiana, United States
- Vascular Care Group
Wellesley, Massachusetts, United States
- Saint Luke'S Hospital of Kansas City
Kansas City, Missouri, United States
- Mercy Hospital South
St Louis, Missouri, United States
- American Endovascular & Amputation Prevention
West Orange, New Jersey, United States
- Vascular Solutions of North Carolina
Cary, North Carolina, United States
- the Miriam Hospital
Providence, Rhode Island, United States
- Wellmont Cardiology Services
Kingsport, Tennessee, United States
- Va North Texas Medical Center
Dallas, Texas, United States
- Baylor Scott & White, the Heart Hospital Plano
Plano, Texas, United States
- Cardiovascular Associated of East Texas
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Feb 2021
- Primary completion
- 25 Apr 2023
- Completion
- 15 Jun 2023
- Last update posted
- 12 Feb 2026
- Registered enrollment
- 79
- Registry id
- NCT04663867
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.